We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jason Hsu

Jason Hsu MD

Retina Service, Wills Eye Hospital, Associate Professor of Ophthalmology, Thomas Jefferson University, Wills Eye Physicians-Mid Atlantic Retina, Philadelphia, PA

Co-Director of Retina Research at Wills Eye Hospital

Associate Professor of Ophthalmology, Sidney Kimmel Medical College of Thomas Jefferson University

Partner, Wills Eye Physicians-Mid Atlantic Retina

Disclosures

Dr. Hsu is a consultant for IVERICbio (New York, NY), Gyroscope Therapeutics (London, United Kingdom) and OccuRx Pty Ltd (Melbourne, Australia). He has received grants from Roche/Genentech (San Francisco, CA), Aldeyra Therapeutics (Lexington, MA) and IVERICbio (New York, NY).

Recent Contributions to PracticeUpdate:

  1. Effects of Loss to Follow-Up After Anti–VEGF Therapy in DME